1. Home
  2. AlgoTherapeutics

Category: InnoBio2

Omnes, Bpifrance back €12m Series A round for cancer treatment side-effect drug developer AlgoTherapeutix

French biotech company AlgoTherapeutix has raised €12m in a Series A round led by Bpifrance through its InnoBio 2 fund alongside co-investor Omnes.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.